Back to STATE STREET CORP STATE STREET CORP

NKTRNKTR
5 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in Nektar Therapeutics

STATE STREET CORP holds 909,679 shares of NKTR (Nektar Therapeutics), worth $63.5M as of 2026-Q2. The position was increased (+271.7% shares). NKTR represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$63.5M

Current Shares

909,679

Total Value Change

+$62.2M

Total Shares Change

+859,574

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
909,679
+271.7%
$63.5M0.0%$69.81
48
2026-Q1
Increased
244,727
+25.1%
$17.6M0.0%$68.11
35
2025-Q4
Increased
195,656
+51.7%
$8.3M0.0%$41.90
38
2025-Q3
Increased
128,999
+157.5%
$7.3M0.0%$58.92
44
2025-Q2
New
50,105
-
$1.3M0.0%$25.76
39

Other major holders of NKTR: FMR LLC, BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used